MyFinsight
Home
Blog
About
Client Direct Billing
$137,956K
(5.18%↑ Y/Y)
Commercial Insurance
$36,273K
(26.10%↑ Y/Y)
Medicare And Other
Governmental
$27,427K
(28.24%↑ Y/Y)
Gain on
extinguishment of debt (note 6)
$11,181K
Interest income
$1,214K
(-46.35%↓ Y/Y)
Net revenue
$201,656K
(11.21%↑ Y/Y)
Income (loss) before
taxes
$1,826K
(103.99%↑ Y/Y)
Income tax benefit
-$412K
(43.09%↑ Y/Y)
Loss from operations
-$9,771K
(79.48%↑ Y/Y)
Gross profit
$91,878K
(18.92%↑ Y/Y)
Interest expense
$781K
(-16.29%↓ Y/Y)
Other (expense)
income, net
-$17K
(-103.53%↓ Y/Y)
Cost of revenue
$109,778K
(5.48%↑ Y/Y)
Net income (loss)
$2,238K
Total operating
expenses
$101,649K
(-18.61%↓ Y/Y)
General and
administrative
$63,613K
(-11.34%↓ Y/Y)
Sales and marketing
$27,275K
(13.29%↑ Y/Y)
Research and development
$10,761K
(19.26%↑ Y/Y)
Back
Back
Income Statement
NEOGENOMICS INC (NEO)
NEOGENOMICS INC (NEO)
source: myfinsight.com